About Technology Issues FAQ

Links

Official Page

Dual Kinase Inhibition in the Treatment of Breast Cancer: Initial Experience with the EGFR/ErbB‐2 Inhibitor Lapatinib

Dual Kinase Inhibition in the Treatment of Breast Cancer: Initial Experience with the EGFR/ErbB‐2 Inhibitor Lapatinib — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.